MAY 17, 2016 01:21 PM PDT

Staph curbs virulence to enter bloodstream

WRITTEN BY: Kerry Evans
Small genetic changes in Staphylococcus aureus affect how and where these bacteria infect people.

Staph is a normal part of your microbiome - about 29% of the US population carries Staph on their skin or in their noses. (Are you part of the 29%?!) If these cells find their way into your bloodstream, however, you can end up with a life-threatening infection.
 
Staph become less virulent to enter the bloodstream.

Here are some scary Staph statistics. Around 90,000 people are infected with MRSA (methicillin-resistant S. aureus) in the US each year, and nearly 50% of people report recurring MRSA infections. In England, there was a 548% increase in MRSA-related deaths between 2003 and 2004. Last, but not least, almost 20% of bloodstream infections are caused by Staph.

According to University of Wurzburg investigator Thomas Rudel, “recent studies have shown that in some cases Staphylococcus strains in the blood of patients differ substantially from those found in the nose … that is astonishing, as both types of bacteria often are very closely related in genetic terms”.

Rudel and colleagues found that one specific mutation, the loss of function of a gene called “repressor of surface proteins” (rsp), allowed Staph to move from the nose into the bloodstream - where it could cause severe infection. What’s strange is that this mutation actually makes Staph less virulent. Essentially, the toxic strains of Staph that live in your nose acquire an rsp mutation, making them less toxic, but better able to enter the bloodstream.

So, how does this all work? The group found that rsp expression helps Staph kill immune cells - by producing toxins in response to hydrogen peroxide (which is produced by neutrophils), for example. When they infected mice with an rsp mutant, the bacteria produced fewer toxins, but were still able cause abscesses. The mutant bacteria were also able to survive in human blood - they weren’t killed by immune cells. This is probably because the rsp mutation allowed the bacteria to survive inside host cells for an extended period of time, but the mechanisms behind this are not clear.    
 
 

Sources: PNAS, EurekAlert, Health Research Funding
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
OCT 05, 2018
Microbiology
OCT 05, 2018
Reducing Pollution with Engineered Bacteria
A varsity of creative strategies have been proposed as solutions to climate change, from practical to outlandish....
OCT 16, 2018
Microbiology
OCT 16, 2018
Simple Test Rapidly Diagnoses Antibiotic-resistant Infections
If we get a bacterial infection, doctors use antibiotics to treat it. But sometimes people are infected by pathogens that are resistant to drugs....
OCT 25, 2018
Microbiology
OCT 25, 2018
Common Herbicides Increase Antibiotic Resistance
If we have to feed a growing planet, it may hurt us in the long run if the methods used in farming are actually increasing antibiotic-resistance in bacteria....
NOV 02, 2018
Microbiology
NOV 02, 2018
As the Climate Warms, Lyme Disease Cases Will Increase
Ticks are known to carry infectious illnesses; Lyme disease is North America's most common tick-borne disease....
NOV 03, 2018
Microbiology
NOV 03, 2018
Potential new Tuberculosis Treatment Found in Dirt
The pathogen that causes TB has been able to evolve, and often, the typical therapeutic for the illness does not work....
DEC 07, 2018
Microbiology
DEC 07, 2018
Epigenetic Inheritance is Revealed in Archaea
Researchers may have found a great new way to study tags that are added to the genome, which change how genes are expressed....
Loading Comments...